「重要なお知らせ:日本語書籍をご購入いただき、eLibraryをご利用の皆さまへ」
エルゼビアは、より快適にサービスをご利用いただくため、システムの重要なアップ
デートを実施いたしました。
現在eLibraryで日本語電子書籍をご利用のお客様は、今後より高いアクセシビリティとセ
キュリティを備えた新しいプラットフォーム「eBooks+」へアカウントが移行されてい
ます。eBooks+のご利用については
こちらよりご利用・ご登録ください。
Diabetes is a chronic disease that is reaching an epidemic proportion in many parts of the world. Despite the high incidence of diabetes, individuals diagnosed with the disorder are only 50%. The main challenge
of medical professionals in diagnosing and treating the diabetic patients is the lack of understanding of the disease, which usually leads to problems with treatment compliance and monitoring.
There is strong evidence to show that an effective intensive glycemic control reduces various microvascular and neuropathic complications of diabetes mellitus. The Diabetes Control and Complications Trial (DCCT) showed that the intensive glycemic control prevented diabetic complications in type 1 diabetic patients, and the HbA1c levels reduced by 1.5–2.0%. In the UKPDS study, a modest improvement in HbA1c (a difference of 0.9 %) in the intensively treated group than in the control group brought about a 25% reduction in microvascular complications and a 12% reduction in all diabetes related events. There are several methods with differing utilities and limitations existing for monitoring glycemic status in individuals.
Diabetes care in India leaves much to be desired and suggested, and there is a need for efforts to increase awareness of both the patients and the doctors for better treatment and monitoring.